Clinical Trial Update: NST-SPARK: Preliminary Study of an Augmented Reality (AR) App Delivering Recovery-Oriented Cognitive Therapy for Negative Symptoms in Schizophrenia [NA]

View source ↗

Summary

The NST-SPARK trial reports completion of a preliminary study evaluating an augmented reality app delivering recovery-oriented cognitive therapy for negative sy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• NST-SPARK AR app

Snippet

Sponsor: North Shore Therapeutics, Inc. | Conditions: Negative Symptoms in Schizophrenia, Schizophrenia | NA | Status: COMPLETED